04:24 PM EDT, 07/16/2025 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) after trade Wednesday said it closed a public offering of share units that raised $15 million in gross proceeds.

The company sold 12-million units at $1.25 each, with each unit made up of either one share or a pre-funded warrant, plus one additional warrant. The pre-funded warrants can be converted to shares at $0.001 each, while the additional warrants allow investors to buy shares at $1.50 over the next five years, according to the statement.

BriaCell added that it plans to use the funds for general business needs, working capital, and furthering its research and development goals.

The company's shares closed up $0.07 to $1.13 on the Toronto Stock Exchange.